Skip to main content

Advertisement

SpringerLink
Log in

Serum total PSA and free PSA in breast tumors

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Now a days measurement of molecular forms of PSA has gained importance in clinical practice. Several studies have demonstrated the production of PSA in female tissues, such as breast. The present piece of work has been undertaken with an objective to estimate the relative proportion of the molecular forms of PSA in serum along with serum testosterone in benign and malignant breast tumor cases and to analyze their association with the severity of the disease process 34 malignant and 26 benign breast disease cases along with 33 healthy controls of same age group were enrolled in this study for evaluation. Serum testosterone was measured by ELISA, whereas serum total PSA (TPSA) and free PSA (FPSA) were estimated by electrochemiluminescence immunoassay. A significant rise of fasting plasma glucose along with prominent dyslipidemia was observed in breast tumor cases. Marked rise in serum testosterone as well as TPSA and FPSA was documented in both benign and malignant breast tumor cases. Serum testosterone revealed a significant positive association with both TPSA and FPSA pointing towards an etiological association between them. However, surgical removal of tumor mass resulted in a marked decline of presurgical value of both TPSA and FPSA with a non-significant fall in serum testosterone revealing tumor tissue as the source of FPSA and TPSA. Thus, estimation of PSA provides prognostic information that may assist in future treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Chart 1
Graph 1

Similar content being viewed by others

References

  1. ICMR Bulletin. Estrogen and breast cancer, Feb 2003,32(2):13–16.

    Google Scholar 

  2. McCormack RT, Rittenhouse HG, Finlay JA. Molecular forms of prostate specific antigen and the human kallikrein gene family: a new era. Urology. 1995;45:729–44.

    Article  PubMed  CAS  Google Scholar 

  3. Catalona WJ, Smith DS, Ratliff TL. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–61.

    Article  PubMed  CAS  Google Scholar 

  4. Filella X, Molina R, Alcover J, Carretero P, Ballesta AM. Detection of nonprostatic PSA in serum and non serum samples from women. Int J Cancer. 1996;68(4):424–7.

    Article  PubMed  CAS  Google Scholar 

  5. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer. 1997;75:579–88.

    Article  PubMed  CAS  Google Scholar 

  6. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker for androgen excess. J Clin Endo Metab 1997(b); 82:777–780.

    Google Scholar 

  7. Melegos DN, Diamandis EP. Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer. Clin Biochem. 1996;29:193–200.

    Article  PubMed  CAS  Google Scholar 

  8. Black MH, Giai M, Ponzone R, Sismondi P, Yu H, Diamandis EP. Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Clin Cancer Res. 2000;6:467–73.

    PubMed  CAS  Google Scholar 

  9. Romppanen J, Keskikuru R, Kataja V, Eskelinen M, Kosma VM, Savolainen K, et al. Measurement of prostate-specific antigen in detection of benign or malignant disease in women. Br J Cancer. 1999;79:1583–7.

    Article  PubMed  CAS  Google Scholar 

  10. Narita D, Cimpean AM, Anghel A, Raica M. Prostate-specific antigen value as a marker in breast cancer. Neoplasma. 2006;53(2):161–7.

    PubMed  CAS  Google Scholar 

  11. Hautmann S, Huland E, Grupp C, Haese A, Huland H. Super-sensitive prostate specific antigen (PSA) in serum of women with benign breast disease or breast cancer. Anticancer Res. 2000;20(3B):2151–4.

    PubMed  CAS  Google Scholar 

  12. Baum M. The Breast. In: Russell RCG, William NS, Bulstrode CJK, editors. Bailey & Love’s short practice of surgery. 24th ed. London: International students Edition; 2004. p. 835–839.

  13. American Joint Committee on Cancer (AJCC). In: Greene FL, Page DL, Fleming ID, editors. Cancer staging manual. 6th ed. Springer, New York; 2002. p. 223–240.

  14. Kricka LJ. Optical techniques. In: Tietz Textbook of clnical chemistry and molecular diagnostics, 4th ed. 2006; Chapter 3, 84–85.

  15. Blackburn GF, Shah HP, Kenten JH. Electrochemiluminescence development of immunoassays and DNA probe assays for clinical diagnostics. Clin Chem. 1991;37:1534–9.

    PubMed  CAS  Google Scholar 

  16. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991;145:907–23.

    PubMed  CAS  Google Scholar 

  17. Akdas A, Cevik I, Tarcan T, Turkeri L, Dalaman G, Emerk K. The role of free prostate-specific antigen in the diagnosis of prostate cancer. Br J Urol. 1997;79:920–3.

    PubMed  CAS  Google Scholar 

  18. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1361–8.

    PubMed  CAS  Google Scholar 

  19. Kaulsay KK. Serum IGF-binding protein-6 and prostate specific antigen in breast cancer. Eur J Endocrinol. 1999;140:164–8.

    Article  PubMed  CAS  Google Scholar 

  20. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995;87(3):190–7.

    Article  PubMed  CAS  Google Scholar 

  21. Hasija K, Bagga HK. Alterations of serum cholesterol and serum lipoprotein in breast cancer of women. Indian J Clin Biochem. 2005;20(1):61–6.

    Article  CAS  Google Scholar 

  22. Jain D, Ray A, Bahadur AK, Chaturbedi KU, Sood R, Sharma S, Naik SLO, Sharma BK. Status of epidermal growth factor receptors family in hormone dependant carcinomas of the breast and prostate with reference to serum lipids and lipoproteins. Indian J Clin Biochem. 2001;16(1):42–51.

    Article  CAS  Google Scholar 

  23. Hulka BS, Stark AT. Breast cancer: cause and prevention. Lancet. 1995;346:883–7.

    Article  PubMed  CAS  Google Scholar 

  24. Gupta SK. Serum testosterone and dehydroepiandrosterone in Indian breast cancer patients in relation to menstrual status and parity; UICC World Cancer Congress: Bridging the gap: Transforming knowledge into Action, Washington DC, USA, July 8–12, 2006.

  25. Bhatavdekar JM, Patel DD, Shah NG, Giri DD, Vora HH, Karelia NH, Trivedi SN, Ghosh N, Suthar TP. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients. Neoplasma. 1992;39(1):39–42.

    PubMed  CAS  Google Scholar 

  26. Secreto G, Toniolo P, Pisani P, Recchione C, Cavalleri A, Fariselli G, Totis A, Di Pietro S, Berrino F. Androgens and breast cancer in premenopausal women. Cancer Res. 1989;49:471–6.

    PubMed  CAS  Google Scholar 

  27. Magklara A, Grass L, Diamandis EP. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res Treat. 2000;59:263–70.

    Article  PubMed  CAS  Google Scholar 

  28. Narita D, Raica M, Suciu C, Cîmpean A, Anghel A. Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer. Folia Histochem Cytobiol. 2006;44(3):165–72.

    PubMed  Google Scholar 

  29. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-β and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun. 1993;192:940–7.

    Article  PubMed  CAS  Google Scholar 

  30. Webber MM, Waghray A, Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res. 1995;1:1089–94.

    PubMed  CAS  Google Scholar 

  31. Cohen P, Peehl DM, Graves HCB, Rosenfeld RG. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 1994;142:407–15.

    Article  PubMed  CAS  Google Scholar 

  32. Oh Y, Gucev Z, Ng L, Muller HL, Rosenfeld RG. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 on human breast cancer cells. Prog Growth Factor Res. 1995;6:503–12.

    Article  PubMed  CAS  Google Scholar 

  33. Fortier AH, Nelson BJ, Grella DK, Holaday JW. Antiangiogenic activity of prostate-specific antigen. J Natl Cancer Inst. 1999;91(19):1635–40.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, S.C.B.Medical College, Cuttack, 753007, India

    Prakruti Dash, Sanghamitra Pati, Manaswini Mangaraj, Pratima Kumari Sahu & Prakash Chandra Mohapatra

  2. Department of Biochemistry, IMS and SUM Hospital, Siksha O Anusandhan University, Bhubaneswar, Orissa, 751003, India

    Prakruti Dash

Authors
  1. Prakruti Dash
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanghamitra Pati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manaswini Mangaraj
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pratima Kumari Sahu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prakash Chandra Mohapatra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prakruti Dash.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dash, P., Pati, S., Mangaraj, M. et al. Serum total PSA and free PSA in breast tumors. Ind J Clin Biochem 26, 182–186 (2011). https://doi.org/10.1007/s12291-011-0115-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-011-0115-5

Keywords

Search

Navigation